PetVivo Holdings SG&A Expenses 2011-2024 | PETV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

PetVivo Holdings sg&a expenses from 2011 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

PetVivo Holdings sg&a expenses from 2011 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$200.4B
Intuitive Surgical (ISRG)	$186.8B
Edwards Lifesciences (EW)	$44.1B
Alcon (ALC)	$41.8B
IQVIA Holdings (IQV)	$35.8B
IDEXX Laboratories (IDXX)	$33.8B
DexCom (DXCM)	$31.3B
Waters (WAT)	$21.9B
STERIS (STE)	$20.5B
SONOVA HOLDING (SONVY)	$19.7B
Hologic (HOLX)	$16.3B
Fresenius Medical Care AG KGaA (FMS)	$13.4B
Sysmex ADR (SSMXY)	$11.8B
Globus Medical (GMED)	$11.3B
Penumbra (PEN)	$9.3B
Masimo (MASI)	$9.1B
Glaukos (GKOS)	$8.3B
Teleflex (TFX)	$8.3B
Integer Holdings (ITGR)	$4.5B
PROCEPT BioRobotics (PRCT)	$4.2B
Inari Medical (NARI)	$3.2B
Veracyte (VCYT)	$3.2B
LivaNova (LIVN)	$2.6B
Nihon Kohden (NHNKY)	$2.4B
Tandem Diabetes Care (TNDM)	$2.4B
Elekta AB (EKTAY)	$2.1B
TransMedics (TMDX)	$2.1B
Integra LifeSciences Holdings (IART)	$1.7B
RxSight (RXST)	$1.4B
Alphatec Holdings (ATEC)	$1.3B